Literature DB >> 29592974

Sodium nitroprusside, a lifesaving treatment for neonatal hypertension: an Irish experience.

Alina Gina Deliu1, Phani Bhushan Jeerigehalli Sanneerappa2, Orla Franklin3, Johannes Letshwiti1.   

Abstract

We present a 30+2-weeks-old (30 weeks and 2 days) male, twin 1, born by emergency caesarean section due to twin-twin transfusion syndrome (absent end-diastolic flow and cardiac anomaly in twin 2) presenting with hypertensive crisis on day 3. He was already on milrinone and propranolol. His echocardiogram showed poor left ventricular contractility and after cardiology consultation received sodium nitroprusside, which eventually saved his life by decreasing his blood pressure and improving cardiac function. As sodium nitroprusside is very rarely used for hypertensive crisis in neonates, we would like to share our experiences on dosage, challenges in administration due to its fast onset of action, criteria for monitoring for complications and finally weaning. Baby developed severe bilateral periventricular leukomalacia as a potential complication of hypertensive crisis, preceded by bilateral periventricular flare secondary to twin-twin transfusion. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cardiovascular system; heart failure; neonatal intensive care; paediatrics (drugs and medicines); therapeutic indications

Mesh:

Substances:

Year:  2018        PMID: 29592974      PMCID: PMC5878390          DOI: 10.1136/bcr-2017-221856

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Nicardipine to control neonatal hypertension during extracorporeal membrane oxygen support.

Authors:  Brian F McBride; C Michael White; Margaret Campbell; Bruce M Frey
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

2.  Sodium nitroprusside: pharmacology, toxicology and therapeutics.

Authors:  J H Tinker; J D Michenfelder
Journal:  Anesthesiology       Date:  1976-09       Impact factor: 7.892

Review 3.  Sodium-nitroprusside-induced cyanide toxicity in pediatric patients.

Authors:  Christopher Thomas; Lindsay Svehla; Brady S Moffett
Journal:  Expert Opin Drug Saf       Date:  2009-09       Impact factor: 4.250

4.  Systemic hypertension requiring treatment in the neonatal intensive care unit.

Authors:  Raj Sahu; Hariyadarshi Pannu; Robert Yu; Sanjay Shete; John T Bricker; Monesha Gupta-Malhotra
Journal:  J Pediatr       Date:  2013-02-07       Impact factor: 4.406

5.  Use of vitamin B12 in the treatment and prevention of nitroprusside-induced cyanide toxicity.

Authors:  N F Zerbe; B K Wagner
Journal:  Crit Care Med       Date:  1993-03       Impact factor: 7.598

6.  Minoxidil-associated anorexia in an infant with refractory hypertension.

Authors:  Zachary A Vesoulis; Stephanie J Attarian; Brandy Zeller; Francis Sessions Cole
Journal:  Pharmacotherapy       Date:  2014-10-03       Impact factor: 4.705

7.  Use of sodium nitroprusside in neonates: efficacy and safety.

Authors:  W E Benitz; N Malachowski; R S Cohen; D K Stevenson; R L Ariagno; P Sunshine
Journal:  J Pediatr       Date:  1985-01       Impact factor: 4.406

Review 8.  Managing hypertension in the newborn infants.

Authors:  Azar Nickavar; Farahnak Assadi
Journal:  Int J Prev Med       Date:  2014-03

Review 9.  Sodium nitroprusside in 2014: A clinical concepts review.

Authors:  Daniel G Hottinger; David S Beebe; Thomas Kozhimannil; Richard C Prielipp; Kumar G Belani
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-10

10.  Neonatal circulatory failure due to acute hypertensive crisis: clinical and echocardiographic clues.

Authors:  Jacoba Louw; Stephen Brown; Liesbeth Thewissen; Anne Smits; Benedicte Eyskens; Ruth Heying; Bjorn Cools; Elena Levtchenko; Karel Allegaert; Marc Gewillig
Journal:  Cardiovasc J Afr       Date:  2013-04       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.